Historical record - last NADAC publication: 6/19/2024
Product Information
BIOFREEZE 4% GEL is a brand product labeled by RB Health (US) LLC, priced at $0.0621 per ML under NDC 59316010228. Its NADAC has been published 7 times since May 22, 2024.
Strength
40 mg/mL
Manufacturer
RB Health (US) LLCNDC
59316010228
Classification
Brand
Dosage Form
GEL
Route
TOPICAL
Last Updated
6/19/2024
Active Ingredients
MENTHOL, UNSPECIFIED FORMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M017On Market Since
1/3/2012
Price Statistics
The NADAC for BIOFREEZE 4% GEL has been published 7 times since May 22, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0621 per ML |
|---|---|
| All-time high | $0.0621 (Jul 3, 2024) |
| All-time low | $0.0610 (May 22, 2024) |
| Median price | $0.0610 |
| Average price | $0.0615 |
| Largest weekly change | +1.9% (Jun 19, 2024) |
| Weeks tracked | 7 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BIOFREEZE 4% GEL?
The current National Average Drug Acquisition Cost (NADAC) for BIOFREEZE 4% GEL, manufactured by RB Health (US) LLC, is $0.0621 per ML (NDC 59316010228), effective Jul 3, 2024.
How has the price of BIOFREEZE 4% GEL changed over time?
Over the history we have for it, the NADAC for BIOFREEZE 4% GEL has held within roughly two percent of its current level. It has been tracked across 7 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for BIOFREEZE 4% GEL?
Since May 22, 2024, the NADAC for BIOFREEZE 4% GEL has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.0621 (Jul 3, 2024), with a median of $0.0610 per ML.
Are there cheaper alternatives to BIOFREEZE 4% GEL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BIOFREEZE 4% GEL, but none are currently priced below it.
Who manufactures BIOFREEZE 4% GEL?
BIOFREEZE 4% GEL (NDC 59316010228) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification